Guang Jia1, Ronney Abaza2,
Joanna D. Williams3, Debra L. Zynger3, Jinyuan Zhou4,
Zarine K. Shah1, Mitva Patel1, Steffen Sammet1,
Lai Wei5, Robert R. Bahnson2, Michael V. Knopp1
1Wright Center of
Innovation in Biomedical Imaging & Department of Radiology, The Ohio
State University, Columbus, OH, United States; 2Department of
Urology, The Ohio State University, Columbus, OH, United States; 3Department
of Pathology, The Ohio State University, Columbus, OH, United States; 4Department
of Radiology, Johns Hopkins University, Baltimore, MD, United States; 5Center
for Biostatistics, The Ohio State University, Columbus, OH, United States
APT-MR imaging was first applied to the prostate in this feasibility study and the initial experience from 12 prostate cancer patients reveals increased MR imaging-detectable mobile proteins in cancerous regions of the prostate.